Aktiferrin 30 ml of drops for oral administration
- $9.60
Out Of Stock
The instruction for medical use
of Aktiferrin medicine ®
the Trade name
of Aktiferrin®
the International unlicensed name
Is not present
the Dosage form
of the Drop for intake, 30 ml
Structure
of 100 ml of drug contain
active agents: gland (II) sulfate gemigidrat 4.720 g, D, the L-serine micronized 3.560 g,
excipients: potassium to atsesulfa, ascorbic acid, Natrium benzoicum, acid of chlorohydrogen 25%, polyethyleneglycol 400, caramel dye, fragrance blackcurrant, the water purified.
The description
Transparent, brownish-yellow solution with a smell and taste of blackcurrant
Pharmacotherapeutic group
hematopoiesis Stimulators. Iron preparations. Iron preparations (II) for oral administration.
The ATX B03AA code
the Pharmacological
Pharmacokinetics Later properties of intake the iron which is a part of the drug Aktiferrin® rather fully is absorbed from digestive tract in a system blood stream. Extent of absorption depends on expressiveness of deficiency of iron (the more deficit, the absorption is higher). The maximum concentration of iron in blood serum is reached within the first 2-4 hours after administration of drug. It is removed with a stake, urine and then.
A pharmacodynamics
Iron is necessary for activity of an organism: it is a part of hemoglobin, a myoglobin, various enzymes, reversibly connects oxygen and participates in a number of redoxreactions, stimulates an erythrogenesis. Aktiferrina® which is a part alpha amino acid serine promotes more effective absorption of iron and its receipt in a system blood stream, leading to fast recovery of its normal contents in an organism. It provides the best tolerance of drug and allows to reduce a necessary dose of iron. Administration of drug of Aktiferrina® of a drop stimulates an erythrogenesis, normalizes hematologic indicators, contributes to normalization of concentration of iron in blood serum that leads to gradual regression clinical (weakness, fatigue, dizziness, tachycardia, dryness of integuments) and laboratory symptoms.
Indications
- treatment and prevention of an iron deficiency anemia
accept the Route of administration and doses of Aktiferrin® inside just before food or at meal time with a small amount of liquid (fruit tea or water). If the attending physician did not appoint other dosages, then it is necessary to adhere to the instructions given below strictly.
Drops of Aktiferrin® - the most convenient form for newborns and children of younger age: The daily dose is established at the rate of 5 drops on 1 kg of body weight, frequency rate of appointment - 2-3 times a day.
Babies: till 10-15 drops 3 times a day.
Children of preschool age: till 25-35 drops 3 times a day.
Children of school age: on 50 drops 3 times a day. After achievement of normal indicators of hemoglobin the Aktiferrin® drug treatment is continued within not less than 8-12 weeks.
Side effects
of the Drop of Aktiferrin® it is usually well transferred by patients of any age.
Often
- nausea, feeling of weight in epigastric area, the meteorism, constipations or diarrhea disappearing at reduction of a dose or at administration of drug with food
Seldom
- allergic skin reactions
of the Contraindication
- hypersensitivity to drug components
- hemochromatosis, a hemosiderosis
- other types of anemias which are not caused by deficiency of iron in an organism (for example, sideroakhrestichesky anemia, anemia in a plumbism, a thalassemia, hemolytic, megaloblastny, aplastic anemias)
Medicinal interactions
At co-administration of the drug Aktiferrin® and:
- tetracyclines, giraza inhibitors (for example, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin), biphosphonates, Penicillaminum, a levodopa, karbidopa and Methyldopums - their absorption decreases,
- thyroxine – thyroxine absorption decreases,
- zinc – zinc absorption decreases,
- vitamin E at children – the efficiency of vitamin E decreases.
- the holestiramina, antacids (containing aluminum, magnesium, calcium or bismuth), additives, calciferous and magnesium - decreases iron absorption,
- non-steroidal anti-inflammatory drugs - the irritating effect of iron on a mucous membrane of digestive tract can increase.
The above-stated means are recommended to be accepted in 2-3 hours prior to reception of Aktiferrina®.
Vitamin C or citric acid increase iron absorption.
Glucocorticoids perhaps strengthen stimulation эритропоэзаАктиферрином®.
Special instructions
With care
It is necessary to be careful at combined use of iron preparations with the dietary products and additives containing iron salts (possible risk of overdose).
At patients with inflammation and ulcers of a mucous membrane of digestive tract, it is necessary to estimate a ratio of advantage of treatment and risk of development of exacerbations of gastroenterological diseases against the background of therapy of iron preparations.
At appointment as sick diabetes it must be kept in mind that 1 ml of drops contains 64 mg of glucose that is equivalent to 0.0053 grain units.
If necessary degree of deficiency of iron and the subsequent requirement of a zameshchaniye of iron should be monitorirovat on the following laboratory indicators with intervals of about 4 weeks: hemoglobin, erythrocytes, reticulocytes, serumal iron, transferrin. Ferritin level indicates less than 15 mkg/l lack of reserves of iron in an organism.
For prevention of emergence on teeth of patients of a reversible black stain of a drop of Aktiferrin® it is not necessary to accept in an undiluted look, and after meal it is recommended to brush teeth carefully.
The drop of Aktiferrin® is not washed down with black tea, coffee, milk in order to avoid decrease in absorption of iron. Besides, reduction of absorption can be caused: firm food, bread, crude cereals, dairy products, eggs. At reception of drops of Aktiferrin® the calla in black color is noted coloring that is not clinically significant.
Pregnancy and the period of a lactation
Preclinical trials on reproductive function were not conducted.
Use at pregnancy and in the period of a lactation perhaps if the potential advantage for mother exceeds potential risk for a fruit and the child.
The feature of influence on ability to run the vehicle and potentially dangerous mechanisms
does not influence ability to run transport or other moving mechanical equipment.
The overdose
is available For children high risk of intoxication iron preparations, zhizneugrozhayushchy states can arise at reception of 1 g of ferrous sulfate. Therefore iron preparations have to be stored out of children's reach.
Symptoms: nausea, an abdominal pain, diarrhea, vomiting, in hard cases - cyanosis, confusion of consciousness, hyperventilation symptoms, in 12-48 h the development of shock with Cheyna-Stokes's breath, oligurias, jaundices because of toxic hepatitis, a toxic liver failure is possible. In certain cases – disturbances of the central nervous system, such as paralysis, spasms, coma, disturbances of blood clotting.
Treatment: before transportation in hospital – intake of milk, crude egg. Before performing specific therapy - a measure for removal of drug from a GIT (calling of vomiting, gastric lavage with bicarbonate and phosphatic solutions), symptomatic therapy of shock and acidosis. Specific therapy carry out at concentration of serumal iron 300-350 mkg/dl by prescribing of Deferoxaminum (Desferal) of 1-2 g intravenously by drop infusion at the rate of 15 mg/kg of body weight an hour each 3-12 hour. In acute poisonings for the iron binding which is not soaked up from digestive tract yet give in 5-10 g of drug by dissolution of contents of 10-20 ampoules in drinking water.
To patients with oligo and an anury at overdose by salts of iron appoint peritoneal or a hemodialysis.
A form of release and packing
On 30 ml in glass bottles droppers of brown color with the screwing-up cover. On 1 bottle together with the instruction for medical use in the state and Russian languages put in a box of cardboard.
To Store storage conditions out of children's reach at a temperature not above 25 °C.
The use period after the first opening is 1 month.
2 years
not to apply a period of storage after an expiration date.
Prescription status
According to the prescription
the Producer/packer
of Merkle GmbH, Germany
the Owner of the registration certificate
"ratiofarm GmbH", Germany
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)
of ratiofarm Kazakhstan LLP, Almaty, Al-Farabi Ave. 19, BC Nurly-Tau, 1B, office 603, ph. (727) 3110915, fax: (727) 3110734, e-mail:
To Develop teva@teva.kz
of Aktiferrin medicine ®
the Trade name
of Aktiferrin®
the International unlicensed name
Is not present
the Dosage form
of the Drop for intake, 30 ml
Structure
of 100 ml of drug contain
active agents: gland (II) sulfate gemigidrat 4.720 g, D, the L-serine micronized 3.560 g,
excipients: potassium to atsesulfa, ascorbic acid, Natrium benzoicum, acid of chlorohydrogen 25%, polyethyleneglycol 400, caramel dye, fragrance blackcurrant, the water purified.
The description
Transparent, brownish-yellow solution with a smell and taste of blackcurrant
Pharmacotherapeutic group
hematopoiesis Stimulators. Iron preparations. Iron preparations (II) for oral administration.
The ATX B03AA code
the Pharmacological
Pharmacokinetics Later properties of intake the iron which is a part of the drug Aktiferrin® rather fully is absorbed from digestive tract in a system blood stream. Extent of absorption depends on expressiveness of deficiency of iron (the more deficit, the absorption is higher). The maximum concentration of iron in blood serum is reached within the first 2-4 hours after administration of drug. It is removed with a stake, urine and then.
A pharmacodynamics
Iron is necessary for activity of an organism: it is a part of hemoglobin, a myoglobin, various enzymes, reversibly connects oxygen and participates in a number of redoxreactions, stimulates an erythrogenesis. Aktiferrina® which is a part alpha amino acid serine promotes more effective absorption of iron and its receipt in a system blood stream, leading to fast recovery of its normal contents in an organism. It provides the best tolerance of drug and allows to reduce a necessary dose of iron. Administration of drug of Aktiferrina® of a drop stimulates an erythrogenesis, normalizes hematologic indicators, contributes to normalization of concentration of iron in blood serum that leads to gradual regression clinical (weakness, fatigue, dizziness, tachycardia, dryness of integuments) and laboratory symptoms.
Indications
- treatment and prevention of an iron deficiency anemia
accept the Route of administration and doses of Aktiferrin® inside just before food or at meal time with a small amount of liquid (fruit tea or water). If the attending physician did not appoint other dosages, then it is necessary to adhere to the instructions given below strictly.
Drops of Aktiferrin® - the most convenient form for newborns and children of younger age: The daily dose is established at the rate of 5 drops on 1 kg of body weight, frequency rate of appointment - 2-3 times a day.
Babies: till 10-15 drops 3 times a day.
Children of preschool age: till 25-35 drops 3 times a day.
Children of school age: on 50 drops 3 times a day. After achievement of normal indicators of hemoglobin the Aktiferrin® drug treatment is continued within not less than 8-12 weeks.
Side effects
of the Drop of Aktiferrin® it is usually well transferred by patients of any age.
Often
- nausea, feeling of weight in epigastric area, the meteorism, constipations or diarrhea disappearing at reduction of a dose or at administration of drug with food
Seldom
- allergic skin reactions
of the Contraindication
- hypersensitivity to drug components
- hemochromatosis, a hemosiderosis
- other types of anemias which are not caused by deficiency of iron in an organism (for example, sideroakhrestichesky anemia, anemia in a plumbism, a thalassemia, hemolytic, megaloblastny, aplastic anemias)
Medicinal interactions
At co-administration of the drug Aktiferrin® and:
- tetracyclines, giraza inhibitors (for example, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin), biphosphonates, Penicillaminum, a levodopa, karbidopa and Methyldopums - their absorption decreases,
- thyroxine – thyroxine absorption decreases,
- zinc – zinc absorption decreases,
- vitamin E at children – the efficiency of vitamin E decreases.
- the holestiramina, antacids (containing aluminum, magnesium, calcium or bismuth), additives, calciferous and magnesium - decreases iron absorption,
- non-steroidal anti-inflammatory drugs - the irritating effect of iron on a mucous membrane of digestive tract can increase.
The above-stated means are recommended to be accepted in 2-3 hours prior to reception of Aktiferrina®.
Vitamin C or citric acid increase iron absorption.
Glucocorticoids perhaps strengthen stimulation эритропоэзаАктиферрином®.
Special instructions
With care
It is necessary to be careful at combined use of iron preparations with the dietary products and additives containing iron salts (possible risk of overdose).
At patients with inflammation and ulcers of a mucous membrane of digestive tract, it is necessary to estimate a ratio of advantage of treatment and risk of development of exacerbations of gastroenterological diseases against the background of therapy of iron preparations.
At appointment as sick diabetes it must be kept in mind that 1 ml of drops contains 64 mg of glucose that is equivalent to 0.0053 grain units.
If necessary degree of deficiency of iron and the subsequent requirement of a zameshchaniye of iron should be monitorirovat on the following laboratory indicators with intervals of about 4 weeks: hemoglobin, erythrocytes, reticulocytes, serumal iron, transferrin. Ferritin level indicates less than 15 mkg/l lack of reserves of iron in an organism.
For prevention of emergence on teeth of patients of a reversible black stain of a drop of Aktiferrin® it is not necessary to accept in an undiluted look, and after meal it is recommended to brush teeth carefully.
The drop of Aktiferrin® is not washed down with black tea, coffee, milk in order to avoid decrease in absorption of iron. Besides, reduction of absorption can be caused: firm food, bread, crude cereals, dairy products, eggs. At reception of drops of Aktiferrin® the calla in black color is noted coloring that is not clinically significant.
Pregnancy and the period of a lactation
Preclinical trials on reproductive function were not conducted.
Use at pregnancy and in the period of a lactation perhaps if the potential advantage for mother exceeds potential risk for a fruit and the child.
The feature of influence on ability to run the vehicle and potentially dangerous mechanisms
does not influence ability to run transport or other moving mechanical equipment.
The overdose
is available For children high risk of intoxication iron preparations, zhizneugrozhayushchy states can arise at reception of 1 g of ferrous sulfate. Therefore iron preparations have to be stored out of children's reach.
Symptoms: nausea, an abdominal pain, diarrhea, vomiting, in hard cases - cyanosis, confusion of consciousness, hyperventilation symptoms, in 12-48 h the development of shock with Cheyna-Stokes's breath, oligurias, jaundices because of toxic hepatitis, a toxic liver failure is possible. In certain cases – disturbances of the central nervous system, such as paralysis, spasms, coma, disturbances of blood clotting.
Treatment: before transportation in hospital – intake of milk, crude egg. Before performing specific therapy - a measure for removal of drug from a GIT (calling of vomiting, gastric lavage with bicarbonate and phosphatic solutions), symptomatic therapy of shock and acidosis. Specific therapy carry out at concentration of serumal iron 300-350 mkg/dl by prescribing of Deferoxaminum (Desferal) of 1-2 g intravenously by drop infusion at the rate of 15 mg/kg of body weight an hour each 3-12 hour. In acute poisonings for the iron binding which is not soaked up from digestive tract yet give in 5-10 g of drug by dissolution of contents of 10-20 ampoules in drinking water.
To patients with oligo and an anury at overdose by salts of iron appoint peritoneal or a hemodialysis.
A form of release and packing
On 30 ml in glass bottles droppers of brown color with the screwing-up cover. On 1 bottle together with the instruction for medical use in the state and Russian languages put in a box of cardboard.
To Store storage conditions out of children's reach at a temperature not above 25 °C.
The use period after the first opening is 1 month.
2 years
not to apply a period of storage after an expiration date.
Prescription status
According to the prescription
the Producer/packer
of Merkle GmbH, Germany
the Owner of the registration certificate
"ratiofarm GmbH", Germany
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)
of ratiofarm Kazakhstan LLP, Almaty, Al-Farabi Ave. 19, BC Nurly-Tau, 1B, office 603, ph. (727) 3110915, fax: (727) 3110734, e-mail:
To Develop teva@teva.kz
Related Products
Immacule Lifesciences Private Limited (India)
Trenaxa (Tranexamic Acid) 100 mg/ml, 5 ampoules. x 5 ml
$57.10
